246 related articles for article (PubMed ID: 1533333)
21. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
22. Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation.
Visentainer JE; Lieber SR; Persoli LB; de Souza Lima SC; Vigorito AC; Aranha FJ; Eid KA; Oliveira GB; Miranda EC; de Souza CA
Braz J Med Biol Res; 2002 May; 35(5):567-72. PubMed ID: 12011942
[TBL] [Abstract][Full Text] [Related]
23. Quantitative assessment of posttransplant host-specific interleukin-2-secreting T-helper cell precursors in patients with and without acute graft-versus-host disease after allogeneic HLA-identical sibling bone marrow transplantation.
Nierle T; Bunjes D; Arnold R; Heimpel H; Theobald M
Blood; 1993 Feb; 81(3):841-8. PubMed ID: 8427976
[TBL] [Abstract][Full Text] [Related]
24. No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients.
Murata M; Emi N; Hirabayashi N; Hamaguchi M; Goto S; Wakita A; Tanimoto M; Saito H; Kodera Y; Morishita Y;
Int J Hematol; 2000 Oct; 72(3):371-5. PubMed ID: 11185997
[TBL] [Abstract][Full Text] [Related]
25. Histocompatibility and bone marrow transplantation (BMT).
Richter KV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287
[TBL] [Abstract][Full Text] [Related]
26. HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling.
Martin PJ; Gooley T; Anasetti C; Petersdorf EW; Hansen JA
Biol Blood Marrow Transplant; 1998; 4(3):128-33. PubMed ID: 9923410
[TBL] [Abstract][Full Text] [Related]
27. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
[TBL] [Abstract][Full Text] [Related]
28. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation.
Cukrová V; Dolezalová L; Loudová M; Matĕjková E; Korínková P; Lukásová M; Starý J
Neoplasma; 1995; 42(1):3-8. PubMed ID: 7617071
[TBL] [Abstract][Full Text] [Related]
29. Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
Alimoghaddam K; Ghaffari H; Foroughi F; Chardouli B; Sanaat Z; Bahar B; Mousavi A; Iravani M; Ghavamzadeh A
Arch Iran Med; 2006 Apr; 9(2):99-103. PubMed ID: 16649348
[TBL] [Abstract][Full Text] [Related]
30. Significance of MLC for BMT with serological HLA-identical related and unrelated donors.
Bonfichi M; Bernasconi P; Brera C; Boni M; Caldera C; Campagnoli C; Alessandrino EP; Bernasconi C
Bone Marrow Transplant; 1993; 11 Suppl 1():28-30. PubMed ID: 8448540
[No Abstract] [Full Text] [Related]
31. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
32. Mixed leukocyte culture reactivity, HLA-DP typing and GVHD.
Moreau P; Milpied N; Cesbron A; Mahe B; Bignon JD; Harousseau JL
Bone Marrow Transplant; 1993 Jan; 11(1):85-6. PubMed ID: 8431717
[No Abstract] [Full Text] [Related]
33. Measurement of recipient-specific alloreactivity: is GVHD predictable?
Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
[TBL] [Abstract][Full Text] [Related]
34. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors.
Martin PJ
Bone Marrow Transplant; 1991 Sep; 8(3):217-23. PubMed ID: 1958902
[TBL] [Abstract][Full Text] [Related]
35. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients.
Dickinson AM; Sviland L; Hamilton PJ; Usher P; Taylor P; Jackson G; Dunn J; Proctor SJ
Bone Marrow Transplant; 1994 Jan; 13(1):65-70. PubMed ID: 8019455
[TBL] [Abstract][Full Text] [Related]
36. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
[TBL] [Abstract][Full Text] [Related]
37. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation.
Marijt EA; Veenhof WF; Goulmy E; Kluck PM; Brand A; Willemze R; van Rood JJ; Falkenburg JH
Hum Immunol; 1993 Aug; 37(4):221-8. PubMed ID: 8300407
[TBL] [Abstract][Full Text] [Related]
38. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
Doney K; Fisher LD; Appelbaum FR; Buckner CD; Storb R; Singer J; Fefer A; Anasetti C; Beatty P; Bensinger W
Bone Marrow Transplant; 1991 Jun; 7(6):453-9. PubMed ID: 1873592
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic bone marrow transplantation in children from other than HLA-identical sibling donor.
Locatelli F; Bongiorno M; Zecca M; Giani S; Giorgiani G; Guagnini R; Morandi P; Porta F; Nespoli L; Burgio GR
Bone Marrow Transplant; 1991; 7 Suppl 3():124-7. PubMed ID: 1855074
[TBL] [Abstract][Full Text] [Related]
40. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia.
Passweg JR; Tiberghien P; Cahn JY; Vowels MR; Camitta BM; Gale RP; Herzig RH; Hoelzer D; Horowitz MM; Ifrah N; Klein JP; Marks DI; Ramsay NK; Rowlings PA; Weisdorf DJ; Zhang MJ; Barrett AJ
Bone Marrow Transplant; 1998 Jan; 21(2):153-8. PubMed ID: 9489632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
